Loading live market data…

Cigna Corporation

NYSE:CI

$297.81 USD

-$5.54 (-1.83%)

Volume
1.37M
Average Volume
1.64M
Market Capitalization
$78.78B
P/E Ratio
12.56
Dividend Yield
2.06%
Price Target
$340.00
Year High
$315.47
Year Low
$239.51
Day High
Day Low
Payout Ratio
$0.26
Current Ratio
$0.82
Source Headline
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (July 2026)

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.1%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.

seekingalpha.com - 2026-07-11 08:15:00

Here's Why Cigna (CI) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-07-07 10:41:28

The Cigna Group's Second Quarter 2026 Earnings Release Details

BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a conference call the same day.

prnewswire.com - 2026-07-07 06:00:00

Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward

Cigna's Evernorth launched AI-powered Pharmacy Forward to speed up specialty prescriptions, cut delays and boost efficiency with a $100M investment.

zacks.com - 2026-07-02 15:11:03

Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions

New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidence BLOOMFIELD, Conn., July 1, 2026 /PRNewswire/ -- As specialty care becomes more complex, patients need faster, more connected, and personalized support.

prnewswire.com - 2026-07-01 08:00:00

Can Cigna's Expansion Beyond Health Insurance Fuel Long-Term Growth?

CI is evolving beyond traditional insurance, using AI, specialty pharmacy and healthcare services to drive growth and sharpen its business focus.

zacks.com - 2026-06-25 11:21:05

The Cigna Group Foundation Honors David M. Cordani's Leadership with New Grant to Strengthen Military Communities

New "Courage in Service" grant builds on company's long-standing support for military and veteran communities. BLOOMFIELD, Conn.

prnewswire.com - 2026-06-25 10:14:00

Here's Why Cigna (CI) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-06-24 10:50:34

The Cigna Group Foundation Invests $3 Million to Strengthen Youth Mental Health Through Nonprofits Across 10 States

22 nonprofits will expand access to youth mental health care and strengthen support for families and caregivers States: Arizona, Connecticut, Florida, Georgia, Illinois, Missouri, New Jersey, Pennsylvania, Tennessee and Texas BLOOMFIELD, Conn., June 23, 2026  /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced $3 million in grants to 22 nonprofits working to improve youth mental health and strengthen support systems across 10 states.

prnewswire.com - 2026-06-23 10:00:00

CI Global Asset Management Announces June 2026 Distributions for Certain CI ETFs

TORONTO--(BUSINESS WIRE)--CI Global Asset Management announces cash distributions for the month or quarter ending June 30, 2026 for certain ETFs managed by CI GAM.

businesswire.com - 2026-06-22 07:00:00

Why Cigna (CI) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-18 10:41:19

Despite Uncertainties the U.S. Economy Powers On

Despite global geopolitical uncertainties and the ongoing conflict in the Middle East, the U.S. economy is showing signs of accelerating growth in the second quarter after a relatively soft start to the year. As often happens, stock market volatility is creating a lot of unease that masks the positive fundamentals.

etftrends.com - 2026-06-17 16:51:41

The Healthcare M&A Wave

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.

forbes.com - 2026-06-17 12:30:08

CI Global Asset Management Announces June 2026 Distributions for the CI ETFs

TORONTO--(BUSINESS WIRE)-- #CIFinancial--CI Global Asset Management announces the regular cash distributions for the CI ETFs for the month or quarter ending June 30, 2026.

businesswire.com - 2026-06-15 07:00:00

Cigna's Express Scripts sues to block law on prescription access in Tennessee

Cigna's pharmacy ​benefits services ‌unit Express Scripts on ​Friday ​requested that the ⁠court ​strike down ​an unlawful state law that ​would ​restrict access to ‌prescription ⁠medications and health care ​for ​hundreds ⁠of thousands of ​residents ​in ⁠Tennessee.

reuters.com - 2026-06-12 15:02:54

ChatGPT portfolio crushes stock market, gains 60%

ChatGPT's simulated investment portfolio has emerged as one of the standout performers in 2026, delivering an approximately 60% year-to-date gain and significantly outperforming the broader stock market.

finbold.com - 2026-06-07 11:06:52

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (June 2026)

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.2%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.

seekingalpha.com - 2026-06-06 08:15:00

Humana Jumps 6%, UnitedHealth Climbs 5%, Cigna Rises 4% as Analysts Cheer Softer Medical Cost Trends

Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside.

247wallst.com - 2026-06-04 13:32:55

5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation

Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.

zacks.com - 2026-06-03 11:25:34

Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan

CNBC's Becky Quick reports on the latest news.

youtube.com - 2026-06-03 07:37:00

Exclusive: Cigna drops coverage of GLP-1 obesity drugs for its own employees

Health insurer Cigna will ​stop covering GLP-1 weight-loss ‌drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in ​its employee health plan ​effective July 1, according to ⁠materials viewed by Reuters on ​Tuesday.

reuters.com - 2026-06-02 17:43:49

Here's Why Cigna (CI) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-05-28 10:40:43

MJH Life Sciences® recognized with 2025 Cigna Healthy Workforce Designation™

CRANBURY, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Cigna Healthcare® has selected MJH Life Sciences® as a recipient of its 2025 gold-level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program.

globenewswire.com - 2026-05-27 10:30:00

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Vernova, Intel, Okta, Travelers, Occidental Petroleum, and More

Pre-Market Stock Futures: Futures are trading higher as investors return to a holiday-shortened trading week after a record-setting Friday, when the S&P 500, which posted its eighth straight weekly gain, and the Dow Jones Industrial Average both posted new all-time highs, closing at 7,473 and 50,579, respectively. Not to be left behind, the Nasdaq closed... Here Are Tuesday's Top Wall Street Analyst Research Calls: Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Vernova, Intel, Okta, Travelers, Occidental Petroleum, and More

247wallst.com - 2026-05-26 08:13:53

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation may as well. All of the major indices finished Tuesday lower, and with Q1 earnings all but over and the incoming economic data... Here Are Wednesday's Top Wall Street Analyst Research Calls: BJ's Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

247wallst.com - 2026-05-20 07:59:49

AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.

247wallst.com - 2026-05-19 09:25:13

Cigna: Shares Marching To Full Recovery

Cigna Group is reiterated as a "Buy," driven by strong Q1 2026 results, raised guidance, and sustained business momentum. CI's pharmacy and behavioral health segments are fueling revenue growth, while divestitures and PBM reform temporarily temper 2026 earnings. Shares trade at a 25% discount to a $377 fair value estimate, offering potential 15% annual total returns through 2031.

seekingalpha.com - 2026-05-18 08:00:00

Here's Why Investors Should Hold On to Cigna Stock for Now

CI trades below the industry's forward P/E as Evernorth's growth, earnings beats and shareholder returns support its long-term outlook.

zacks.com - 2026-05-15 15:31:15

The Cigna Group (CI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

The Cigna Group (CI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-13 16:40:56

The Cigna Group Announces Appearance at the BofA Securities 2026 Health Care Conference

BLOOMFIELD, Conn., May 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and Chief Operating Officer of The Cigna Group, will present at the BofA Securities 2026 Health Care Conference today, May 13, 2026, in Las Vegas, NV.

prnewswire.com - 2026-05-13 06:00:00

The Cigna Group (CI) Stock Up 3.6% and Still Undervalued -- GF Score: 72/100

On May 12, 2026, The Cigna Group (CI) shares rose 3.6% to a current price of $298.49. The stock has experienced a 52-week range, with a high of $338.89 and a lo

gurufocus.com - 2026-05-12 19:16:00

Why Cigna (CI) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-05-12 10:41:31

Why Cigna (CI) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-05-07 10:50:24

Why Cigna (CI) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-05-06 10:45:35

Major health insurers show signs of recovery – but a key test looms

Solid first-quarter results from major insurers like UnitedHealth, Elevance, Cigna and Humana have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. But analysts caution that insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real proving ground.

cnbc.com - 2026-05-05 07:00:01

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (May 2026)

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.74%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.

seekingalpha.com - 2026-05-02 08:00:00

Cigna Q1 Earnings Support A Higher Valuation

Cigna Group (CI) delivers robust quarterly results, with adjusted EPS up 16% and revenue up 5%, reinforcing core business resilience. CI raises 2026 adjusted EPS outlook to at least $30.35, reflecting confidence in margin expansion and ongoing shareholder returns via buybacks and dividends. Valuation remains compelling at 9.6x forward earnings, with strong cash flow, disciplined capital deployment, and a solid balance sheet supporting the Buy rating.

seekingalpha.com - 2026-05-01 10:12:15

Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit

CI beats Q1 EPS estimates as Evernorth revenues jump 9% despite rising pharmacy costs; 2026 EPS outlook lifted to at least $30.35.

zacks.com - 2026-04-30 16:11:07

Cigna Raises Outlook, Flags Individual Exchange Exit And Strategic Review Of eviCore

The Cigna Group (NYSE:CI) shares are marginally down on Thursday as the company reported first-quarter results.

benzinga.com - 2026-04-30 14:58:12

The Cigna Group (CI) Q1 2026 Earnings Call Transcript

The Cigna Group (CI) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-30 12:01:38

Cigna (CI) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-04-30 10:30:24

Cigna is becoming the second major insurer to exit from the ACA market as millions drop coverage with the expiration of federal subsidies.

Cigna Group will exit the Affordable Care Act market next year, citing an effort to focus on other lines of business.

wsj.com - 2026-04-30 09:42:00

Cigna Plans To Exit Obamacare In 2027 Affecting 369,000 With Coverage

The Cigna Group Thursday confirmed plans to exit the individual health insurance business also known as Obamacare next year, leaving about 369,00 health plan members in 11 states looking for new coverage in 2027.

forbes.com - 2026-04-30 08:55:38

Cigna (CI) Q1 Earnings and Revenues Beat Estimates

Cigna (CI) came out with quarterly earnings of $7.79 per share, beating the Zacks Consensus Estimate of $7.62 per share. This compares to earnings of $6.74 per share a year ago.

zacks.com - 2026-04-30 08:11:20

Cigna Revenue Rises on Evernorth Growth

Cigna Group logged higher profit and revenue in its latest quarter as its pharmacy-benefit business Evernorth continued to grow.

wsj.com - 2026-04-30 06:06:00

Cigna raises annual profit forecast after quarterly beat

Cigna slightly raised its annual adjusted profit forecast on Thursday after beating first-quarter earnings estimates, helped ​by strength in its health services unit ‌and as medical costs came in lower than expected.

reuters.com - 2026-04-30 06:04:02

The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook

Total revenues for the first quarter 2026 increased 5% to $68.5 billion Shareholders' net income for the first quarter 2026 was $1.7 billion, or $6.26 per share Adjusted income from operations1 for the first quarter 2026 was $2.1 billion, or $7.79 per share 2026 outlook2 for adjusted income from operations1,2 increased to at least $30.35 per share2 BLOOMFIELD, Conn., April 30, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported first quarter 2026 results, reflecting growth across its diversified portfolio of businesses.

prnewswire.com - 2026-04-30 06:00:00

Comerica Bank Has $13.94 Million Holdings in Cigna Group $CI

Comerica Bank cut its position in Cigna Group (NYSE: CI) by 14.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,658 shares of the health services provider's stock after selling 8,758 shares during the quarter. Comerica Bank's holdings in Cigna Group

defenseworld.net - 2026-04-29 14:41:29

Baron Capital Recognized with 2025 Cigna Healthy Workforce Designation™

NEW YORK--(BUSINESS WIRE)--Cigna Healthcare® has selected Baron Capital as a recipient of their 2025 gold level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program. Baron Capital's approach to employee health and wellness continues to grow and adapt to the evolving needs of its workforce. Through expanded access to preventive care, education, and supportive resources, the Firm aims to ma.

businesswire.com - 2026-04-29 09:00:00

Cigna (CI) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Cigna (CI) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

zacks.com - 2026-04-28 10:17:06

Get CI Insider Trade Alerts

CI Price Target Summary

Last Month

$348.00

2 analysts

Last Quarter

$340.08

13 analysts

Last Year

$335.22

36 analysts

All Time

$328.70

82 analysts

CI Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-09 Bernstein Maintain Outperform Outperform
2026-06-08 Mizuho Maintain Outperform Outperform
2026-05-26 Barclays Downgrade Overweight Equal Weight
2026-05-22 UBS Maintain Buy Buy
2026-05-20 Deutsche Bank Downgrade Buy Hold
2026-05-20 Morgan Stanley Maintain Overweight Overweight
2026-05-05 Bernstein Maintain Outperform Outperform
2026-05-04 Guggenheim Maintain Buy Buy
2026-05-01 Cantor Fitzgerald Maintain Overweight Overweight
2026-05-01 RBC Capital Maintain Outperform Outperform
2026-05-01 Barclays Maintain Overweight Overweight
2026-05-01 Wells Fargo Maintain Equal Weight Equal Weight
2026-04-20 Jefferies Maintain Buy Buy
2026-03-12 Bernstein Upgrade Market Perform Outperform
2026-03-03 Piper Sandler Maintain Overweight Overweight
2026-02-17 Truist Securities Maintain Buy Buy
2026-02-09 TD Cowen Maintain Buy Buy
2026-02-06 Guggenheim Maintain Buy Buy
2026-02-06 Barclays Maintain Overweight Overweight
2026-02-06 RBC Capital Maintain Outperform Outperform
2026-02-02 Guggenheim Maintain Buy Buy
2026-01-05 Barclays Maintain Overweight Overweight
2026-01-05 Truist Securities Maintain Buy Buy
2025-11-12 Bernstein Maintain Market Perform Market Perform
2025-11-05 Wells Fargo Maintain Equal Weight Equal Weight
2025-11-04 TD Cowen Maintain Buy Buy
2025-11-04 Goldman Sachs Maintain Buy Buy
2025-11-04 JP Morgan Maintain Overweight Overweight
2025-11-03 Barclays Maintain Overweight Overweight
2025-09-04 Barclays Maintain Overweight Overweight
2025-08-26 Cantor Fitzgerald Maintain Overweight Overweight
2025-08-14 Wells Fargo Maintain Equal Weight Equal Weight
2025-08-14 Baird Maintain Outperform Outperform
2025-08-04 Guggenheim Maintain Buy Buy
2025-08-01 Barclays Maintain Overweight Overweight
2025-06-26 RBC Capital Maintain Outperform Outperform
2025-06-03 RBC Capital Maintain Outperform Outperform
2025-06-02 Barclays Maintain Overweight Overweight
2025-05-23 Guggenheim Maintain Buy Buy
2025-05-12 Truist Securities Maintain Buy Buy
2025-05-06 Guggenheim Maintain Buy Buy
2025-05-05 Raymond James Maintain Strong Buy Strong Buy
2025-05-05 Guggenheim Maintain Buy Buy
2025-05-05 Piper Sandler Maintain Overweight Overweight
2025-05-05 Barclays Maintain Overweight Overweight
2025-05-05 Morgan Stanley Maintain Overweight Overweight
2025-04-15 Baird Maintain Outperform Outperform
2025-04-11 Truist Securities Maintain Buy Buy
2025-04-09 Mizuho Maintain Outperform Outperform
2025-03-20 Cantor Fitzgerald Maintain Overweight Overweight
2025-02-04 Wells Fargo Maintain Equal Weight Equal Weight
2025-02-04 Truist Securities Maintain Buy Buy
2025-02-03 UBS Maintain Buy Buy
2025-02-03 Piper Sandler Maintain Overweight Overweight
2025-01-31 RBC Capital Maintain Outperform Outperform
2025-01-31 Stephens & Co. Maintain Overweight Overweight
2025-01-31 Barclays Maintain Overweight Overweight
2025-01-31 Morgan Stanley Maintain Overweight Overweight
2025-01-31 Stephens& Co. Maintain Overweight Overweight
2025-01-31 Raymond James Maintain Strong Buy Strong Buy
2025-01-31 Oppenheimer Maintain Outperform Outperform
2025-01-31 Cantor Fitzgerald Maintain Overweight Overweight
2025-01-06 Truist Securities Maintain Buy Buy
2024-11-05 Piper Sandler Maintain Overweight Overweight
2024-11-05 Barclays Maintain Overweight Overweight
2024-11-04 Deutsche Bank Maintain Buy Buy
2024-11-01 RBC Capital Maintain Outperform Outperform
2024-11-01 Stephens & Co. Maintain Overweight Overweight
2024-08-21 JP Morgan Maintain Overweight Overweight
2024-08-19 Cantor Fitzgerald Maintain Overweight Overweight
2024-08-02 Barclays Maintain Overweight Overweight
2024-08-02 Stephens & Co. Maintain Overweight Overweight
2024-07-10 Cantor Fitzgerald Maintain Overweight Overweight
2024-06-12 Cantor Fitzgerald Maintain Overweight Overweight
2024-05-30 JP Morgan Maintain Overweight Overweight
2024-05-03 Oppenheimer Maintain Outperform Outperform
2024-05-03 Cantor Fitzgerald Maintain Overweight Overweight
2024-04-10 Cantor Fitzgerald Maintain Overweight Overweight
2024-03-08 Truist Securities Maintain Buy Buy
2024-03-08 Cantor Fitzgerald Maintain Overweight Overweight
2024-03-08 RBC Capital Maintain Outperform Outperform
2024-03-08 Mizuho Maintain Buy Buy
2024-03-08 UBS Maintain Buy Buy
2024-03-04 Morgan Stanley Maintain Overweight Overweight
2024-03-04 Cantor Fitzgerald Maintain Overweight Overweight
2024-02-06 Wells Fargo Maintain Equal Weight Equal Weight
2024-02-05 RBC Capital Upgrade Sector Perform Outperform
2024-02-05 Mizuho Maintain Buy Buy
2024-02-05 Cantor Fitzgerald Upgrade Neutral Overweight
2024-02-01 Deutsche Bank Upgrade Hold Buy
2024-01-19 Cantor Fitzgerald Maintain Neutral Neutral
2024-01-17 Oppenheimer Maintain Outperform Outperform
2024-01-04 Bernstein Upgrade Market Perform Outperform
2023-12-12 Deutsche Bank Maintain Hold Hold
2023-12-11 Jefferies Upgrade Hold Buy
2023-11-30 RBC Capital Maintain Sector Perform Sector Perform
2023-11-15 RBC Capital Maintain Sector Perform Sector Perform
2023-11-03 Cantor Fitzgerald Maintain Neutral Neutral
2023-11-03 RBC Capital Maintain Sector Perform Sector Perform
2023-09-14 Cantor Fitzgerald Maintain Neutral Neutral
2023-08-18 Edward Jones Downgrade Buy Hold
2023-08-07 Raymond James Maintain Strong Buy Strong Buy
2023-08-04 B of A Securities Maintain Buy Buy
2023-07-13 UBS Maintain Buy Buy
2023-07-07 JP Morgan Maintain Overweight Overweight
2023-06-28 Stephens & Co. Maintain Overweight Overweight
2023-06-20 Truist Securities Maintain Buy Buy
2023-06-06 B of A Securities Upgrade Neutral Buy
2023-05-08 Deutsche Bank Maintain Hold Hold
2023-05-08 RBC Capital Maintain Sector Perform Sector Perform
2023-05-08 Wells Fargo Maintain Equal Weight Equal Weight
2023-05-08 Raymond James Maintain Strong Buy Strong Buy
2023-04-26 Bernstein Maintain Market Perform Market Perform
2023-04-21 Cantor Fitzgerald Maintain Neutral Neutral
2023-04-05 Raymond James Upgrade Outperform Strong Buy
2023-03-30 Mizuho Maintain Buy Buy
2023-03-21 Stephens & Co. Maintain Overweight Overweight
2023-02-28 Stephens & Co. Maintain Overweight Overweight
2023-02-23 JP Morgan Maintain Overweight Overweight
2023-02-08 SVB Leerink Maintain Market Perform Market Perform
2023-02-07 Raymond James Maintain Outperform Outperform
2023-02-06 Stephens & Co. Maintain Overweight Overweight
2023-01-06 Morgan Stanley Maintain Overweight Overweight
2023-01-03 Wells Fargo Downgrade Overweight Equal Weight
2022-11-21 Raymond James Downgrade Strong Buy Outperform
2022-11-10 Mizuho Maintain Buy Buy
2022-11-08 SVB Leerink Maintain Market Perform Market Perform
2022-11-07 Credit Suisse Maintain Outperform Outperform
2022-11-07 RBC Capital Maintain Sector Perform Sector Perform
2022-11-07 Raymond James Maintain Strong Buy Strong Buy
2022-08-17 Morgan Stanley Maintain Overweight Overweight
2022-08-12 Raymond James Maintain Strong Buy Strong Buy
2022-08-10 SVB Leerink Maintain Market Perform Market Perform
2022-08-09 Goldman Sachs Maintain Neutral Neutral
2022-08-08 Credit Suisse Maintain Outperform Outperform
2022-08-08 UBS Maintain Buy Buy
2022-08-08 Oppenheimer Maintain Outperform Outperform
2022-08-08 Wells Fargo Maintain Overweight Overweight
2022-08-05 Mizuho Maintain Buy Buy
2022-08-05 RBC Capital Maintain Sector Perform Sector Perform
2022-07-14 Truist Securities Maintain Buy Buy
2022-07-14 Jefferies Downgrade Buy Hold
2022-06-22 Morgan Stanley Upgrade Equal Weight Overweight
2022-06-17 Loop Capital Maintain Hold Hold
2022-06-09 Deutsche Bank Maintain Hold Hold
2022-05-27 Morgan Stanley Maintain Equal Weight Equal Weight
2022-05-26 B of A Securities Upgrade Underperform Neutral
2022-05-23 Barclays Maintain Overweight Overweight
2022-05-16 JP Morgan Upgrade Neutral Overweight
2022-05-10 Raymond James Maintain Strong Buy Strong Buy
2022-05-09 Truist Securities Maintain Buy Buy
2022-05-09 Oppenheimer Maintain Outperform Outperform
2022-05-09 RBC Capital Maintain Sector Perform Sector Perform
2022-05-09 Mizuho Maintain Buy Buy
2022-05-09 Wells Fargo Maintain Overweight Overweight
2022-05-09 Cowen & Co. Upgrade Market Perform Outperform
2022-04-20 Stephens & Co. Maintain Overweight Overweight
2022-03-02 Mizuho Maintain Buy Buy
2022-02-22 SVB Leerink Maintain Market Perform Market Perform
2022-02-10 Morgan Stanley Maintain Equal Weight Equal Weight
2022-02-07 RBC Capital Downgrade Outperform Sector Perform
2022-02-04 Deutsche Bank Downgrade Buy Hold
2022-01-06 Wells Fargo Upgrade Equal Weight Overweight
2021-12-21 JP Morgan Downgrade Overweight Neutral
2021-12-20 Mizuho Maintain Buy Buy
2021-12-17 Morgan Stanley Downgrade Overweight Equal Weight
2021-12-16 Morgan Stanley Downgrade Overweight Equal Weight
2021-12-14 Goldman Sachs Maintain Neutral Neutral
2021-11-17 Seaport Global Maintain Buy Buy
2021-11-12 Morgan Stanley Maintain Overweight Overweight
2021-11-08 Credit Suisse Maintain Outperform Outperform
2021-11-08 BMO Capital Maintain Outperform Outperform
2021-11-05 Jefferies Maintain Buy Buy
2021-10-11 UBS Maintain Buy Buy
2021-09-27 SVB Leerink Maintain Market Perform Perform
2021-09-10 B of A Securities Downgrade Buy Underperform
2021-08-31 Morgan Stanley Maintain Overweight Overweight
2021-08-09 Raymond James Maintain Strong Buy Strong Buy
2021-08-06 Stephens & Co. Maintain Overweight Overweight
2021-08-06 Credit Suisse Maintain Outperform Outperform
2021-08-06 Oppenheimer Maintain Outperform Outperform
2021-06-03 Morgan Stanley Maintain Overweight Overweight
2021-05-19 Wells Fargo Maintain Equal Weight Equal Weight
2021-05-14 RBC Capital Maintain Outperform Outperform
2021-05-10 Credit Suisse Maintain Outperform Outperform
2021-05-10 BMO Capital Maintain Outperform Outperform
2021-02-08 Morgan Stanley Maintain Overweight Overweight
2021-02-05 Citigroup Maintain Buy Buy
2020-12-14 SVB Leerink Maintain Market Perform Market Perform
2020-11-25 JP Morgan Maintain Overweight Overweight
2020-11-25 Susquehanna Maintain Positive Outperform
2020-11-25 Sterne Agee Downgrade Buy Neutral
2020-11-25 Susquehanna Downgrade Positive Neutral
2020-11-25 RBC Capital Maintain Outperform Outperform
2020-11-25 Jefferies Downgrade Buy Hold
2020-11-25 Citigroup Downgrade Buy Neutral
2020-11-25 Raymond James Maintain Outperform Outperform
2020-11-25 Citigroup Maintain Hold Hold
2020-11-25 Leerink Swann Maintain Outperform Outperform
2020-11-25 Goldman Sachs Maintain Neutral Neutral
2020-11-25 Wedbush Maintain Neutral Neutral
2020-11-25 Barclays Maintain Equal Weight Equal Weight
2020-11-25 Oppenheimer Maintain Outperform Outperform
2020-11-25 RBC Capital Upgrade Sector Perform Outperform
2020-11-25 Credit Suisse Upgrade Neutral Outperform
2020-11-25 Morgan Stanley Maintain Overweight Overweight
2020-11-25 Bernstein Downgrade Outperform Perform
2020-11-25 Monness Crespi Hardt Downgrade Buy Neutral
2020-11-25 BMO Capital Maintain Outperform Outperform
2020-11-25 Credit Suisse Maintain Outperform Outperform
2020-11-25 Wells Fargo Downgrade Equal Weight Underweight
2020-11-25 Susquehanna Upgrade Neutral Outperform
2020-11-25 Stephens & Co. Maintain Overweight Overweight
2020-11-25 Piper Sandler Maintain Overweight Overweight
2020-11-25 BMO Capital Upgrade Market Perform Outperform
2020-11-25 Bernstein Upgrade Market Perform Outperform
2020-11-25 SVB Leerink Maintain Market Perform Perform
2020-11-25 Raymond James Upgrade Market Perform Outperform
2020-11-25 Cowen & Co. Maintain Outperform Outperform
2020-11-25 SunTrust Robinson Humphrey Maintain Buy Buy
2020-11-25 Goldman Sachs Upgrade Neutral Buy
2020-11-25 Monness Crespi Hardt Upgrade Neutral Buy
2020-11-25 UBS Maintain Buy Buy
2020-11-25 Deutsche Bank Maintain Buy Buy
2020-11-25 Mizuho Maintain Buy Buy
2020-11-25 Jefferies Maintain Buy Buy
2020-11-25 Jefferies Upgrade Hold Buy
2020-11-25 Monness Crespi Hardt Maintain Buy Buy
2020-11-25 Bank of America Maintain Buy Buy
2020-11-25 Sterne Agee CRT Upgrade Neutral Buy
2020-11-06 SVB Leerink Maintain Market Perform Market Perform
2020-11-06 Raymond James Maintain Strong Buy Strong Buy
2020-08-03 RBC Capital Maintain Outperform Outperform
2020-07-31 SVB Leerink Maintain Market Perform Market Perform
2020-07-01 SVB Leerink Maintain Market Perform Perform
2020-06-05 UBS Maintain Buy Buy
2020-05-04 Bernstein Downgrade Outperform Perform
2020-05-04 Raymond James Maintain Strong Buy Strong Buy
2020-05-04 Barclays Maintain Overweight Overweight
2020-05-04 Bernstein Downgrade Outperform Market Perform
2020-04-13 SunTrust Robinson Humphrey Maintain Buy Buy
2020-04-13 Morgan Stanley Maintain Overweight Overweight
2020-03-27 Morgan Stanley Maintain Overweight Overweight
2020-03-24 Raymond James Maintain Outperform Buy
2020-03-24 Raymond James Upgrade Outperform Strong Buy
2020-03-23 Raymond James Maintain Outperform Outperform
2020-02-25 Piper Sandler Maintain Overweight Overweight
2020-02-18 Deutsche Bank Maintain Buy Buy
2020-02-07 Morgan Stanley Maintain Overweight Overweight
2020-02-07 Raymond James Maintain Outperform Outperform
2020-01-28 UBS Maintain Buy Buy
2020-01-23 Citigroup Maintain Buy Buy
2020-01-02 Stephens & Co. Maintain Overweight Overweight
2019-12-20 JP Morgan Maintain Overweight Overweight
2019-12-19 Deutsche Bank Maintain Buy Buy
2019-12-11 Wells Fargo Downgrade Equal Weight Underweight
2019-11-22 Morgan Stanley Maintain Overweight Overweight
2019-11-18 SunTrust Robinson Humphrey Maintain Buy Buy
2019-11-06 Mizuho Maintain Buy Buy
2019-11-05 UBS Maintain Buy Buy
2019-11-05 Citigroup Maintain Buy Buy
2019-11-01 Deutsche Bank Maintain Buy Buy
2019-09-30 BMO Capital Upgrade Market Perform Outperform
2019-09-26 Morgan Stanley Maintain Overweight Overweight
2019-08-06 Bernstein Upgrade Market Perform Outperform
2019-07-12 Morgan Stanley Maintain Overweight Overweight
2019-04-17 Barclays Maintain Overweight Overweight
2019-02-05 Morgan Stanley Maintain Overweight Overweight
2019-01-03 Raymond James Upgrade Market Perform Outperform
2018-11-19 Leerink Swann Maintain Outperform Outperform
2018-11-02 BMO Capital Maintain Market Perform Market Perform
2018-11-02 Citigroup Maintain Buy Buy
2018-11-02 Barclays Maintain Overweight Overweight
2018-09-18 Credit Suisse Maintain Outperform Outperform
2018-06-06 Goldman Sachs Upgrade Neutral Buy
2018-05-04 Credit Suisse Maintain Outperform Outperform
2018-03-12 Credit Suisse Maintain Outperform Outperform
2018-02-02 Morgan Stanley Maintain Overweight Overweight
2017-11-03 Morgan Stanley Maintain Overweight Overweight
2017-11-03 Citigroup Maintain Buy Buy
2017-11-03 Jefferies Maintain Buy Buy
2017-10-13 Jefferies Maintain Buy Buy
2017-08-17 Morgan Stanley Maintain Overweight Overweight
2017-08-07 Morgan Stanley Maintain Overweight Overweight
2017-08-07 Deutsche Bank Maintain Buy Buy
2017-08-07 Citigroup Maintain Buy Buy
2017-07-13 Deutsche Bank Maintain Buy Buy
2017-02-10 RBC Capital Upgrade Sector Perform Outperform
2016-08-03 Citigroup Maintain Buy Buy
2016-08-01 Jefferies Maintain Buy Buy
2016-02-05 Barclays Maintain Equal Weight Equal Weight
2016-02-05 BMO Capital Maintain Outperform Outperform
2016-01-08 Jefferies Upgrade Hold Buy
2016-01-06 Barclays Maintain Equal Weight Equal Weight
2015-09-22 Cowen & Co. Maintain Outperform Outperform
2015-07-31 Barclays Maintain Equal Weight Equal Weight
2015-07-27 Sterne Agee CRT Upgrade Neutral Buy
2015-07-27 Sterne Agee Upgrade Neutral Buy
2015-07-09 Susquehanna Maintain Positive Positive
2015-06-23 Leerink Swann Maintain Outperform Outperform
2015-06-22 Leerink Swann Maintain Outperform Outperform
2015-06-17 Morgan Stanley Maintain Overweight Overweight
2015-06-16 UBS Maintain Buy Buy
2015-05-01 Barclays Maintain Equal Weight Equal Weight
2015-04-16 Oppenheimer Maintain Outperform Outperform
2015-03-20 Barclays Maintain Equal Weight Equal Weight
2015-02-06 JP Morgan Maintain Overweight Overweight
2015-02-05 Barclays Maintain Equal Weight Equal Weight
2015-01-20 Jefferies Maintain Hold Hold
2015-01-08 Barclays Maintain Equal Weight Equal Weight
2015-01-07 Goldman Sachs Upgrade Neutral Buy
2015-01-06 Deutsche Bank Maintain Buy Buy
2014-11-18 Bank of America Maintain Buy Buy
2014-11-18 B of A Securities Maintain Buy Buy
2014-11-03 Barclays Maintain Equal Weight Equal Weight
2014-10-31 Barclays Maintain Equal Weight Equal Weight
2014-10-30 Deutsche Bank Maintain Buy Buy
2014-10-30 Citigroup Maintain Neutral Neutral
2014-10-30 Oppenheimer Maintain Outperform Outperform
2014-10-30 Credit Suisse Maintain Outperform Outperform
2014-10-15 Sterne Agee Downgrade Buy Neutral
2014-10-14 Sterne Agee Downgrade Buy Neutral
2014-10-07 JP Morgan Maintain Overweight Overweight
2014-09-17 Susquehanna Upgrade Neutral Positive
2014-09-05 Credit Suisse Maintain Outperform Outperform
2014-08-01 Barclays Maintain Equal Weight Equal Weight
2014-07-16 Deutsche Bank Maintain Buy Buy
2014-07-10 Jefferies Maintain Hold Hold
2014-06-03 JP Morgan Maintain Overweight Overweight
2014-05-02 Jefferies Maintain Hold Hold
2014-05-02 Credit Suisse Maintain Outperform Outperform
2014-05-02 Barclays Maintain Equal Weight Equal Weight
2014-05-02 Deutsche Bank Maintain Buy Buy
2014-05-02 Oppenheimer Maintain Outperform Outperform
2014-05-02 Citigroup Maintain Hold Hold
2014-03-31 JP Morgan Maintain Overweight Overweight
2014-02-14 Morgan Stanley Maintain Overweight Overweight
2014-02-07 Susquehanna Downgrade Positive Neutral
2014-01-07 Deutsche Bank Maintain Buy Buy
2013-11-05 Monness Crespi Hardt Downgrade Buy Neutral
2013-11-05 Monness, Crespi, Hardt Downgrade Buy Neutral
2013-10-08 Deutsche Bank Maintain Buy Buy
2013-08-02 Deutsche Bank Maintain Buy Buy
2013-08-02 Oppenheimer Maintain Outperform Outperform
2013-07-16 Deutsche Bank Maintain Buy Buy
2013-07-10 Jefferies Maintain Hold Hold
2013-06-11 Deutsche Bank Maintain Buy Buy
2013-06-11 Goldman Sachs Maintain Neutral Neutral
2013-05-14 Monness, Crespi, Hardt Maintain Buy Buy
2013-05-14 Monness Crespi Hardt Maintain Buy Buy
2013-05-14 Jefferies Downgrade Buy Hold
2013-05-03 Deutsche Bank Maintain Buy Buy
2013-05-03 Jefferies Maintain Buy Buy
2013-04-03 Citigroup Downgrade Buy Neutral
2013-04-02 Jefferies Maintain Buy Buy
2013-04-02 Deutsche Bank Maintain Buy Buy
2013-03-14 JP Morgan Maintain Overweight Overweight
2013-02-14 BMO Capital Maintain Outperform Outperform
2013-02-08 Jefferies Maintain Buy Buy
2013-02-05 Monness Crespi Hardt Upgrade Neutral Buy
2013-02-05 Deutsche Bank Maintain Buy Buy
2013-02-05 Monness, Crespi, Hardt Upgrade Neutral Buy
2012-12-21 BMO Capital Maintain Outperform Outperform
2012-11-02 Deutsche Bank Maintain Buy Buy
2012-11-02 BMO Capital Maintain Outperform Outperform
2012-11-02 Jefferies Maintain Buy Buy
2012-11-02 Goldman Sachs Maintain Neutral Neutral
2012-11-01 Oppenheimer Maintain Outperform Outperform
2012-11-01 Wedbush Maintain Neutral Neutral
2012-10-15 Deutsche Bank Maintain Buy Buy
2012-08-30 Credit Suisse Upgrade Neutral Outperform
2012-08-03 BMO Capital Upgrade Market Perform Outperform
2012-08-03 Deutsche Bank Maintain Buy Buy
2012-05-11 Morgan Stanley Maintain Overweight Overweight
2012-04-09 Wedbush Maintain Neutral Neutral